JP2022500489A5 - - Google Patents
Info
- Publication number
- JP2022500489A5 JP2022500489A5 JP2021532282A JP2021532282A JP2022500489A5 JP 2022500489 A5 JP2022500489 A5 JP 2022500489A5 JP 2021532282 A JP2021532282 A JP 2021532282A JP 2021532282 A JP2021532282 A JP 2021532282A JP 2022500489 A5 JP2022500489 A5 JP 2022500489A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- seq
- pharmaceutical composition
- microbiome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024083941A JP7851353B2 (ja) | 2018-08-17 | 2024-05-23 | 腸内毒素症を減少させ、微生物叢を復元する方法 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862765165P | 2018-08-17 | 2018-08-17 | |
| US62/765,165 | 2018-08-17 | ||
| US201862724185P | 2018-08-29 | 2018-08-29 | |
| US62/724,185 | 2018-08-29 | ||
| US201962815395P | 2019-03-08 | 2019-03-08 | |
| US62/815,395 | 2019-03-08 | ||
| US201962829513P | 2019-04-04 | 2019-04-04 | |
| US62/829,513 | 2019-04-04 | ||
| US201962829959P | 2019-04-05 | 2019-04-05 | |
| US62/829,959 | 2019-04-05 | ||
| PCT/US2019/046926 WO2020037271A1 (en) | 2018-08-17 | 2019-08-16 | Methods of decreasing dysbiosis and restoring a microbiome |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024083941A Division JP7851353B2 (ja) | 2018-08-17 | 2024-05-23 | 腸内毒素症を減少させ、微生物叢を復元する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500489A JP2022500489A (ja) | 2022-01-04 |
| JP2022500489A5 true JP2022500489A5 (https=) | 2022-08-25 |
| JP7558170B2 JP7558170B2 (ja) | 2024-09-30 |
Family
ID=69525842
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532282A Active JP7558170B2 (ja) | 2018-08-17 | 2019-08-16 | 腸内毒素症を減少させ、微生物叢を復元する方法 |
| JP2024083941A Active JP7851353B2 (ja) | 2018-08-17 | 2024-05-23 | 腸内毒素症を減少させ、微生物叢を復元する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024083941A Active JP7851353B2 (ja) | 2018-08-17 | 2024-05-23 | 腸内毒素症を減少させ、微生物叢を復元する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12161680B2 (https=) |
| EP (1) | EP3836946B1 (https=) |
| JP (2) | JP7558170B2 (https=) |
| KR (1) | KR20210091119A (https=) |
| CN (1) | CN112888447A (https=) |
| AU (1) | AU2019321681A1 (https=) |
| IL (2) | IL280779B2 (https=) |
| WO (1) | WO2020037271A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 |
| ES2993669T3 (en) | 2011-12-01 | 2025-01-03 | Univ Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
| CA3226196A1 (en) | 2016-06-14 | 2017-12-21 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
| AU2019321681A1 (en) * | 2018-08-17 | 2021-02-25 | Vedanta Biosciences, Inc. | Methods of decreasing dysbiosis and restoring a microbiome |
| KR102503766B1 (ko) * | 2020-06-16 | 2023-02-23 | 씨제이바이오사이언스 주식회사 | 장내 마이크로바이옴 지수를 결정하기 위한 장치, 방법 및 명령을 기록한 기록 매체 |
| CN111796043B (zh) * | 2020-08-15 | 2022-02-22 | 山东北大高科华泰制药有限公司 | 注射用盐酸罂粟碱粉针剂及其质量检测方法 |
| WO2022159711A1 (en) | 2021-01-21 | 2022-07-28 | Vedanta Biosciences, Inc. | Compositions and methods for treating hepatic encephalopathy |
| EP4362961A1 (en) * | 2021-06-28 | 2024-05-08 | Vedanta Biosciences, Inc. | Methods of colonizing a microbiome, treating and/or preventing inflammatory bowel disease and graft versus host disease |
| CN113486954B (zh) * | 2021-07-06 | 2023-04-07 | 广西爱生生命科技有限公司 | 一种肠道微生态差异菌分类处理方法及肠道健康评估方法 |
| JP2024540203A (ja) * | 2021-11-08 | 2024-10-31 | アルティメット メディシン アーゲー | ミクログリア機能障害を治療し、代謝機能障害を改善するための方法および組成物 |
| CN114496279B (zh) * | 2022-01-12 | 2022-08-30 | 广州保量医疗科技有限公司 | 菌群移植配型的排序方法、系统、计算机设备及存储介质 |
| EP4698197A1 (en) * | 2023-04-20 | 2026-02-25 | Ecole Polytechnique Federale De Lausanne (Epfl) | AN ANTIBIOTIC AND A MICROORGANISM HAVING BILE ACID 7a-DEHYDROXYLATION ACTIVITY FOR TREATING NON-INFECTIOUS DISEASES |
| EP4704871A2 (en) * | 2023-04-28 | 2026-03-11 | Vedanta Biosciences, Inc. | Compositions and methods for treating clostridioides difficile infection |
| WO2025076184A1 (en) | 2023-10-03 | 2025-04-10 | Vedanta Biosciences, Inc. | Methods of decreasing dysbiosis and restoring a microbiome |
| WO2025093778A1 (en) * | 2023-11-05 | 2025-05-08 | Human Biome Institute S.A. | Functional compositions and methods of use thereof in eradication and/or decolonization of antibiotic-resistant bacteria and restoration of healthy microbiota |
| CN119970806B (zh) * | 2025-02-25 | 2026-03-03 | 浙江大学 | 多毛假解黄酮菌在制备预防、治疗和/或改善溃疡性结肠炎的药物中的应用 |
| CN120779034A (zh) * | 2025-07-15 | 2025-10-14 | 中山大学附属口腔医院 | 一种牙周炎相关标志物及应用 |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2248822T3 (es) | 1995-09-15 | 2006-03-16 | Dale N. Gerding | Procedimientos y composiciones para la prevencion y el tratamiento de enfermedades asociadas al clostridium difficile. |
| AUPQ899700A0 (en) * | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| US20090197249A1 (en) | 2004-11-01 | 2009-08-06 | George Mason University | Compositions and methods for diagnosing colon disorders |
| KR101260533B1 (ko) * | 2005-03-03 | 2013-05-06 | 가부시키가이샤 메이지 | 면역기능 조정제 |
| US9603876B2 (en) | 2008-09-25 | 2017-03-28 | New York University | Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment |
| GB0916335D0 (en) * | 2009-09-17 | 2009-10-28 | Martin W J | Medicaments |
| DK3564357T3 (da) * | 2010-02-01 | 2022-06-20 | Rebiotix Inc | Bakterieterapi mod clostridium difficile colitis |
| WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 |
| EP3424515A3 (en) | 2010-08-04 | 2019-06-19 | Thomas Julius Borody | Stool collection devices and methods for using them |
| US9386793B2 (en) | 2010-08-20 | 2016-07-12 | New York University | Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota |
| MX359082B (es) | 2011-05-23 | 2018-09-11 | Washington State Univ Research Foundation | Uso de agentes estabilizantes de pigmento fotosintético para regular la maduración y calidad de frutas y vegetales. |
| US20140363397A1 (en) | 2011-09-14 | 2014-12-11 | Queen's University At Kingston | Method for treatment of disorders of the gastrointestinal system |
| ES2993669T3 (en) | 2011-12-01 | 2025-01-03 | Univ Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
| EP2836224A4 (en) | 2012-02-29 | 2015-12-16 | Ethicon Endo Surgery Inc | COMPOSITIONS OF BIOZOOSE AND RELATED METHODS |
| JP6201982B2 (ja) | 2012-03-30 | 2017-09-27 | 味の素株式会社 | 糖尿病誘起細菌 |
| US10130665B2 (en) | 2012-05-18 | 2018-11-20 | Genome Research Limited | Method for identifying bacteria for bacteriotherapy |
| CN102743420A (zh) | 2012-06-06 | 2012-10-24 | 上海交通大学 | 改善肠道菌群结构的方法及应用 |
| SG11201503966PA (en) | 2012-11-23 | 2015-06-29 | Seres Health Inc | Synergistic bacterial compositions and methods of production and use thereof |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| JP2016509003A (ja) | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
| AU2014239883B2 (en) * | 2013-03-14 | 2019-01-17 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| EP2971148A4 (en) | 2013-03-14 | 2016-08-17 | Seres Therapeutics Inc | METHODS OF DETECTING PATHOGENS AND ENRICHING FROM MATERIALS AND COMPOSITIONS |
| WO2014145958A2 (en) | 2013-03-15 | 2014-09-18 | Seres Health, Inc. | Network-based microbial compositions and methods |
| WO2014150094A1 (en) | 2013-03-15 | 2014-09-25 | University Of Florida Research Foundation, Inc. | Butyrogenic bacteria as probiotics to treat clostridium difficile |
| WO2015006355A2 (en) | 2013-07-09 | 2015-01-15 | Puretech Ventures, Llc | Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease |
| CA2926466C (en) | 2013-10-03 | 2021-11-16 | Frederic Bushman | Compositions comprising a defined microbiome and methods of use thereof |
| CN105979952B (zh) | 2013-11-25 | 2022-04-08 | 赛里斯治疗公司 | 协同细菌组合物以及其制造方法和用途 |
| US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| AU2015244700B2 (en) | 2014-04-10 | 2020-08-27 | Riken | Compositions and methods for induction of Th17 cells |
| EP3134509B1 (en) | 2014-04-23 | 2026-01-21 | Cornell University | Modulation of fat storage in a subject by altering population levels of christensenellaceae in the gi tract |
| US20170087196A1 (en) | 2014-05-19 | 2017-03-30 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for reducing clostridium difficile infection |
| CA2964480A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| WO2016086161A1 (en) | 2014-11-25 | 2016-06-02 | Memorial Sloan-Kettering Cancer Center | Intestinal microbiota and gvhd |
| BR112017024264B1 (pt) | 2015-05-14 | 2022-07-12 | Crestovo Holdings Llc | Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração |
| EA201792547A1 (ru) | 2015-05-21 | 2018-04-30 | Иеда Рисеч Энд Девелопмент Ко. Лтд. | Популяции бактерий для стимуляции состояния здоровья |
| WO2016201053A1 (en) | 2015-06-09 | 2016-12-15 | Regents Of The University Of Minnesota | Methods for detecting risk of having a bloodstream infection and compositions for reducing the risk |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| NZ737752A (en) | 2015-06-15 | 2022-02-25 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| SMT201900588T1 (it) | 2015-06-15 | 2019-11-13 | 4D Pharma Res Limited | Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| WO2016203221A1 (en) | 2015-06-15 | 2016-12-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| JP2018519295A (ja) | 2015-06-22 | 2018-07-19 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 粘膜固有層調節性ｔ細胞の誘導 |
| EP3319619A4 (en) | 2015-07-08 | 2019-01-02 | Seres Therapeutics, Inc. | Methods of treating colitis |
| EP3341000A4 (en) | 2015-08-24 | 2019-02-20 | Nubyiota LLC | SYSTEMS AND METHOD FOR TREATING DYSBIOSIS WITH BACTERIAL POPULATIONS FROM FECALIA |
| MX2018005107A (es) | 2015-10-26 | 2018-08-09 | Crestovo Holdings Llc | Composiciones y metodos para la terapia relacionada con la microbiota fecal. |
| CN108513545B (zh) | 2015-11-20 | 2020-11-03 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| PL3380108T3 (pl) | 2015-11-24 | 2023-03-27 | Seres Therapeutics, Inc. | Zaprojektowane kompozycje bakteryjne |
| ME03487B (me) | 2016-03-04 | 2020-01-20 | 4D Pharma Plc | Kompozicije koje sadrže blautia bakterijske sojeve za liječenje visceralne hipersenzitivnosti |
| US20170290889A1 (en) | 2016-04-11 | 2017-10-12 | New York University | Methods and compositions for treating dysbiosis and gastrointestinal and inflammatory disorders |
| CA3226196A1 (en) | 2016-06-14 | 2017-12-21 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
| US9999641B2 (en) | 2016-06-14 | 2018-06-19 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
| CN109562147B (zh) | 2016-06-28 | 2023-09-01 | 特里瓦生物制剂有限公司 | 保护微生物组免受口服抗生素 |
| US12176071B2 (en) * | 2016-10-26 | 2024-12-24 | The Joan & Irwin Jacobs Technion-Cornell Institute | Systems and methods for ultra-fast identification and abundance estimates of microorganisms using a kmer-depth based approach and privacy-preserving protocols |
| BR112020023933A2 (pt) | 2018-05-24 | 2021-04-27 | Seres Therapeutics, Inc. | composições bacterianas projetadas e usos destas |
| AU2019321681A1 (en) * | 2018-08-17 | 2021-02-25 | Vedanta Biosciences, Inc. | Methods of decreasing dysbiosis and restoring a microbiome |
| WO2022159711A1 (en) | 2021-01-21 | 2022-07-28 | Vedanta Biosciences, Inc. | Compositions and methods for treating hepatic encephalopathy |
-
2019
- 2019-08-16 AU AU2019321681A patent/AU2019321681A1/en active Pending
- 2019-08-16 JP JP2021532282A patent/JP7558170B2/ja active Active
- 2019-08-16 US US17/268,781 patent/US12161680B2/en active Active
- 2019-08-16 KR KR1020217007593A patent/KR20210091119A/ko not_active Ceased
- 2019-08-16 IL IL280779A patent/IL280779B2/en unknown
- 2019-08-16 CN CN201980068341.3A patent/CN112888447A/zh active Pending
- 2019-08-16 WO PCT/US2019/046926 patent/WO2020037271A1/en not_active Ceased
- 2019-08-16 IL IL317775A patent/IL317775A/en unknown
- 2019-08-16 EP EP19849346.2A patent/EP3836946B1/en active Active
-
2024
- 2024-05-23 JP JP2024083941A patent/JP7851353B2/ja active Active
- 2024-10-31 US US18/932,688 patent/US20250161375A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022500489A5 (https=) | ||
| JP2024119856A5 (https=) | ||
| Liu et al. | The microbiome in inflammatory bowel diseases: from pathogenesis to therapy | |
| Wen et al. | Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation | |
| Demeure et al. | Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics | |
| US10597427B2 (en) | Diabetes-inducible bacterium | |
| Kim et al. | Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice | |
| US10660923B2 (en) | Sinusitis diagnostics and treatments | |
| EP3678639B1 (en) | Bacteriophage for modulating inflammatory bowel disease | |
| Safarchi et al. | Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study | |
| Umar et al. | Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings | |
| Elbestawy et al. | Isolation, characterization, and antibiotic sensitivity assessment of Gallibacterium anatis biovar haemolytica, from diseased Egyptian chicken flocks during the years 2013 and 2015 | |
| WO2023222098A1 (en) | A new streptomyces spororaveus strain and a new antibiotics against bacteria and fungi | |
| JP2020529431A5 (https=) | ||
| Phan et al. | Genotyping of Helicobacter pylori shows high diversity of strains circulating in central Vietnam | |
| WO2022092964A1 (ko) | 염증성 장질환 예방 또는 치료용 조성물 | |
| Baird et al. | Genetic variation in Australian spotted fever group rickettsiae | |
| Goel et al. | Molecular characterization reveals involvement of altered El Tor biotype Vibrio cholerae O1 strains in cholera outbreak at Hyderabad, India | |
| KR20250086761A (ko) | 건강을 개선하기 위한 화합물 및 방법 | |
| US20240041950A1 (en) | Decolonization of enterobacteria, such as klebsiella pneumoniae, from the gut using strains of klebsiella oxytoca | |
| Havlickova et al. | Distribution of integrons and SGI1 among antibiotic-resistant Salmonella enterica isolates of animal origin | |
| HUP0203646A2 (hu) | Gyengített mikroorganizmusok alkalmazása fertőzések ellen | |
| Chakrabarti et al. | Brain abscess due to Aspergillus nidulans | |
| Apablaza et al. | Variable Number of Tandem Repeats (VNTR) analysis of Flavobacterium psychrophilum from salmonids in Chile and Norway | |
| WO2020214739A1 (en) | Methods and compositions for treating inflammatory diseases |